Daily Equity Reports 28 March 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 28 THMARCH 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIANEQUITYBENCHMARK- Itisweakclosingforthe benchmarkindicesonWednesdayaftermarketerasedallits morninggainsinthelaterpartoftheday.TheSensexwas NIFTY down 100.53 points at 38,132.88, while Nifty was down CLOSE PREVIOUS 38.30pointsat11,445.About1189shareshaveadvanced, NIKKEI 1524sharesdeclined,and152sharesareunchanged.NTPC, HPCL,TataMotors,BhartiAirtelandEicherMotorswerethe top losers on the Nifty, while gainers include Yes Bank, 2145.62 2148.80 IndusInd Bank, Indiabulls Housing, JSW Steel and SBI. Amongthesectors,energy,auto,FMCG,infra,IT,metaland CLOSE CHANGE (%) pharmaremainedunderpressure,whilesomebuyingseen CNX 100 inthebankingstock,withNiftyBankendedabove30,000 S&P CNX 500 9501.80 level. GLOBALFACE 4974.10 0.36 CNX 200 5977.85 ! BANK NIFTY 0.46 AsianMarket- Asianmarketsfinishedmixedas ofthemost recentclosingprices.TheShanghaiCompositegained0.85% andtheHangSengrose0.56%.TheNikkei225lost0.23%. TOP GAINERS CLOSE CHANGE (%) ! U.S.Market– NorthandSouthAmericanmarketsfinished broadly higheronTuesdaywithsharesinBrazilleadingthe YESBANK 5.87 INDUSINDBK 5.68 region.TheBovespaisup1.76%whileU.S.'sS&P500isup 0.72%andMexico'sIPCisup0.29%. 2.78 ! Europeanmarkets– Europeanmarketsarelowertoday 286.15 1.71 TOP LOSERS whileGermany'sDAXisoff0.39%andLondon'sFTSE100is CLOSE CHANGE (%) lowerby0.32%. 269.25 137.00 169.75 BHARTIARTL 321.60 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY BUY ON DIPS SCRIPT CLOSE (%) 5.87 PIVOT POINTS 1.48 S3 11201 S2 11334 R1 11523 R2 11601 R3 11734 11389 11468 1.33 INFRATEL S1-11338 S2-11245 R1-11598 R2-11685 1.22 ZEEL CLOSE (%) -2.82 HINDPETRO -1.65 HDFC -1.60 -1.58 M&M NET BUY (CR.) NET STRATEGY BUY ON DIPS SELL (CR) BULLISH PIVOT POINTS P 30027 4916.71 S1 29780 R1 30274 R2 R3 31016 29038 29533 30522 RESISTANCE DII 3766.08 NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 3 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS LupingetsUSFDAapprovalfor! TadalafilTabletsUSP Pharma major Lupin Limited (Lupin) announced that it hasreceivedapprovalforitsTadalafilTabletsUSP,2.5mg, 5mg,10mg,and20mg,fromtheUnitedStatesFoodand DrugAdministration(FDA)tomarketagenericversionof EliLillyandCompanysCialisTablets,2.5mg,5mg,10mg, and20mg.LupinsTadalafilTabletsUSP,2.5mg,5mg,10 mg,and20mg,isthegenericequivalentofEliLillyand CompanysCialisTablets,2.5mg,5mg,10mg,and20mg. It is indicatedfor the treatmentof: Erectiledysfunction (ED) The signs and symptoms of benign prostatic hyperplasia(BPH),EDandthesignsandsymptomsofBPH (ED/BPH). ! TataPowerstockrises2%afterMERC approves700MWPPA Shares of Tata Power rose 2% on the BSE in the afternoon session after the company has received approval from Maharashtra Electricity Regulatory Commission(MERC)approvaltosupplythepowerfrom its Trombay Thermal and Hydro plants. Maharashtra ElectricityRegulatoryCommission(MERC)hasallowed theDistributionBusinessofTataPower,Indiaslargest integrated power utility to have a Power Purchase Arrangement(PPA)withitsgenerationarmfor700MW to be supplied from its Trombay Thermal and Hydro plantsforaperiodoffiveyearsfromApril1,2019to March31,2024,thecompanysaidintheBSEfiling. ! Cadilasarmreceives1observationfromUSFDA forAhmedabadplant CadilainitsfilingtotheexchangesonWednesday informedthatthecompanysAlidacPharmaceuticals receivedoneobservationfromtheUSFDAforitsinjectable onco manufacturing facility, Ahmedabad.TheUSFDAhadconductedaPre-Approval Inspection(PAI)forDoxorubicinLiposomal,acomplex oncologicalinjectableatAlidacPharmaceuticalsLtd,the injectableoncomanufacturingfacilityfromMarch18to 26,2019,the companysaidinapressnote. located at Pharmez, ! ICICIPrudentialLifegains9%afterOFS subscribes3.9times SharesofICICIPrudentialLifeInsurancegains9%on Wednesdayaftertheofferforsale(OFS)ofthecompany witnessedsubscriptionof3.9times.Accordingly,investorsbid for210mnsharesagainst53.26mnonsharesonoffer.The53.2 mnsharesalewillfetchPrudential~Rs1,598cr.Thefloorprice forthesalehasbeenfixedatRs300,adiscountof7%toMondays closingpriceofRs322.35. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : INDUSINDBK DATE : 28/03/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY INDUSINDBK IN CASH ABOVE 1805 TGT 1830 SL 1780 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.